Literature DB >> 30324234

Recent advances in the histological and molecular classification of endometrial stromal neoplasms.

Joana Ferreira1,2, Ana Félix3,4, Jochen K Lennerz5, Esther Oliva5.   

Abstract

This review addresses known features and recent developments in the histological, immunohistochemical, and molecular characterization of endometrial stromal neoplasms. We discuss the spectrum of these tumors, from the benign endometrial stromal nodule to low-grade endometrial stromal sarcoma to uterine undifferentiated sarcomas with a special emphasis on the expanding group of high-grade stromal sarcomas, recently added to the 2014 WHO classification, not only discussing the well-established YWHAE-FAM22 tumors but also two new groups, presenting with BCOR alterations including those with BCOR tandem internal duplications or NTRK fusions. It is likely that this high-grade category of endometrial stromal tumors will expand as increasing molecular data is available.

Entities:  

Keywords:  Endometrial stromal sarcoma; Molecular; Sarcoma; Translocations; Uterus

Mesh:

Year:  2018        PMID: 30324234     DOI: 10.1007/s00428-018-2470-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  130 in total

1.  An endometrial stromal sarcoma with clonal cytogenetic abnormalities.

Authors:  C Sreekantaiah; F P Li; N Weidner; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1991-09

2.  IFITM1 Outperforms CD10 in Differentiating Low-grade Endometrial Stromal Sarcomas From Smooth Muscle Neoplasms of the Uterus.

Authors:  Aurelia Busca; Previn Gulavita; Carlos Parra-Herran; Shahidul Islam
Journal:  Int J Gynecol Pathol       Date:  2018-07       Impact factor: 2.762

3.  Ossifying fibromyxoid tumor presenting EP400-PHF1 fusion gene.

Authors:  Makoto Endo; Kenichi Kohashi; Hidetaka Yamamoto; Takeaki Ishii; Tatsuya Yoshida; Tomoya Matsunobu; Yukihide Iwamoto; Yoshinao Oda
Journal:  Hum Pathol       Date:  2013-06-24       Impact factor: 3.466

4.  JAZF1 rearrangement in a mesenchymal tumor of nonendometrial stromal origin: report of an unusual ossifying sarcoma of the heart demonstrating JAZF1/PHF1 fusion.

Authors:  J Kenneth Schoolmeester; William R Sukov; Joseph J Maleszewski; Patrick P Bedroske; Andrew L Folpe; Jennelle C Hodge
Journal:  Am J Surg Pathol       Date:  2013-06       Impact factor: 6.394

5.  Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors.

Authors:  Esther Oliva; Philip B Clement; Robert H Young
Journal:  Int J Gynecol Pathol       Date:  2002-01       Impact factor: 2.762

6.  The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.

Authors:  Cheng-Han Lee; Adrian Mariño-Enriquez; Wenbin Ou; Meijun Zhu; Rola H Ali; Sarah Chiang; Frédéric Amant; C Blake Gilks; Matt van de Rijn; Esther Oliva; Maria Debiec-Rychter; Paola Dal Cin; Jonathan A Fletcher; Marisa R Nucci
Journal:  Am J Surg Pathol       Date:  2012-05       Impact factor: 6.394

7.  High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features.

Authors:  Andrew P Sciallis; Patrick P Bedroske; John K Schoolmeester; William R Sukov; Gary L Keeney; Jennelle C Hodge; Debra A Bell
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

8.  Inhibin and CD99 (MIC2) expression in uterine stromal neoplasms with sex-cord-like elements.

Authors:  R J Baker; R H Hildebrandt; R V Rouse; M R Hendrickson; T A Longacre
Journal:  Hum Pathol       Date:  1999-06       Impact factor: 3.466

9.  Novel fusion of MYST/Esa1-associated factor 6 and PHF1 in endometrial stromal sarcoma.

Authors:  Ioannis Panagopoulos; Francesca Micci; Jim Thorsen; Ludmila Gorunova; Anne Mette Eibak; Bodil Bjerkehagen; Ben Davidson; Sverre Heim
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

10.  Low-grade endometrial stromal sarcoma with extensive sex cord differentiation, heterologous elements, and complex atypical hyperplasia: Case report and review of literature.

Authors:  Abby M Richmond; Andrew J Rohrer; Susan A Davidson; Miriam D Post
Journal:  Gynecol Oncol Rep       Date:  2016-12-14
View more
  10 in total

1.  Can the classification of low-grade endometrial stromal tumors still be improved?

Authors:  Xavier Matias-Guiu; Ben Davidson; Sigurd F Lax
Journal:  Virchows Arch       Date:  2018-10-26       Impact factor: 4.064

2.  ZC3H7B-BCOR high-grade endometrial stromal sarcoma may present as myoma nascens with cytoplasmic signet ring cell change.

Authors:  Ondrej Ondič; Barbora Bednářová; Nikola Ptáková; Veronika Hájková; Petr Šteiner; Henrieta Šidlová; Jiří Presl; Jiří Bouda; Reza Alaghehbandan; Michal Michal
Journal:  Virchows Arch       Date:  2020-01-14       Impact factor: 4.064

Review 3.  [Mesenchymal and mixed uterine tumors : Current overview and practical aspects].

Authors:  S F Lax
Journal:  Pathologe       Date:  2019-02       Impact factor: 1.011

Review 4.  [Endometrial and other rare uterine sarcomas : Diagnostic aspects in the context of the 2020 WHO classification].

Authors:  Doris Mayr; Lars-Christian Horn; Grit Gesine Ruth Hiller; Anne Kathrin Höhn; Elisa Schmoeckel
Journal:  Pathologe       Date:  2022-04-01       Impact factor: 1.011

Review 5.  LG-ESSs and HG-ESSs: underlying molecular alterations and potential therapeutic strategies.

Authors:  Chunhui Li; Chunhong Wang
Journal:  J Zhejiang Univ Sci B       Date:  2021-08-15       Impact factor: 3.066

Review 6.  MR Imaging of uterine sarcomas: a comprehensive review with radiologic-pathologic correlation.

Authors:  Filipa Alves E Sousa; Joana Ferreira; Teresa Margarida Cunha
Journal:  Abdom Radiol (NY)       Date:  2021-09-01

7.  Recurrent chromosomal translocations in sarcomas create a megacomplex that mislocalizes NuA4/TIP60 to Polycomb target loci.

Authors:  Nikita Avvakumov; Marie-Eve Lalonde; Nader Alerasool; Charles Joly-Beauparlant; Karine Jacquet; Amel Mameri; Deepthi Sudarshan; Jean-Philippe Lambert; Justine Rousseau; Catherine Lachance; Eric Paquet; Lara Herrmann; Samarth Thonta Setty; Jeremy Loehr; Marcus Q Bernardini; Marjan Rouzbahman; Anne-Claude Gingras; Benoit Coulombe; Arnaud Droit; Mikko Taipale; Yannick Doyon; Jacques Côté
Journal:  Genes Dev       Date:  2022-06-16       Impact factor: 12.890

8.  Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.

Authors:  Abbas Agaimy; Blaise A Clarke; David L Kolin; Cheng-Han Lee; Jen-Chieh Lee; W Glenn McCluggage; Patrik Pöschke; Robert Stoehr; David Swanson; Gulisa Turashvili; Matthias W Beckmann; Arndt Hartmann; Cristina R Antonescu; Brendan C Dickson
Journal:  Am J Surg Pathol       Date:  2022-05-17       Impact factor: 6.298

9.  YWHAE as an HE4 interacting protein can influence the malignant behaviour of ovarian cancer by regulating the PI3K/AKT and MAPK pathways.

Authors:  Xiao Li; Caixia Wang; Shuang Wang; Yuexin Hu; Shan Jin; Ouxuan Liu; Rui Gou; Xin Nie; Juanjuan Liu; Bei Lin
Journal:  Cancer Cell Int       Date:  2021-06-09       Impact factor: 5.722

10.  Mixed Endometrial Stromal and Smooth Muscle Tumor of the Uterus with Unusual Morphologic Features in a 35-Year-Old Nulliparous Woman: A Case Report.

Authors:  Joo Yeon Kim
Journal:  Am J Case Rep       Date:  2022-04-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.